{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["natural products", "pathogenesis", "probiotics", "prophylaxis", "type III secretion system"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "31554164", "DateRevised": {"Year": "2020", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "09", "Day": "24"}], "Language": ["eng"], "ELocationID": ["162", "10.3390/antibiotics8040162"], "Journal": {"ISSN": "2079-6382", "JournalIssue": {"Volume": "8", "Issue": "4", "PubDate": {"Year": "2019", "Month": "Sep", "Day": "24"}}, "Title": "Antibiotics (Basel, Switzerland)", "ISOAbbreviation": "Antibiotics (Basel)"}, "ArticleTitle": "Natural Product Type III Secretion System Inhibitors.", "Abstract": {"AbstractText": ["Many known inhibitors of the bacterial type III secretion system (T3SS), a virulence factor used by pathogenic bacteria to infect host cells, are natural products. These compounds, produced by bacteria, fungi, and plants, may have developed as prophylactic treatments for potential attack by bacterial pathogens or as an attempt by symbiotic organisms to protect their hosts. Regardless, better understanding of the structures and mechanisms of action of these compounds may open opportunities for drug development against diseases caused by pathogens utilizing the T3SS. This review will cover selected known natural products of the T3SS and detail what is known of their origin and mechanism of action. These inhibitors highlight nature's ability to modulate interactions between organisms at a cellular level."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA 23284, USA. pendergrassha@vcu.edu."}], "LastName": "Pendergrass", "ForeName": "Heather A", "Initials": "HA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA 23284, USA. aemay@vcu.edu."}], "LastName": "May", "ForeName": "Aaron E", "Initials": "AE"}], "GrantList": [{"GrantID": "UL1 TR002649", "Acronym": "TR", "Agency": "NCATS NIH HHS", "Country": "United States"}, {"GrantID": "UL1TR000058", "Acronym": "TR", "Agency": "NCATS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Antibiotics (Basel)", "NlmUniqueID": "101637404", "ISSNLinking": "2079-6382"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Salmond G.P.C., Reeves P.J. Membrane traffic wardens and protein secretion in Gram-negative bacteria. Trends Biochem. Sci. 1993;18:7\u201312. doi: 10.1016/0968-0004(93)90080-7.", "ArticleIdList": ["10.1016/0968-0004(93)90080-7", "8438237"]}, {"Citation": "Cornelis G.R., Gijsegem F.V. Assembly and function of type III secretory systems. Annu. Rev. Microbiol. 2000;54:735\u2013774. doi: 10.1146/annurev.micro.54.1.735.", "ArticleIdList": ["10.1146/annurev.micro.54.1.735", "11018143"]}, {"Citation": "Grado M.A., Abe A.G., Gauthier A., Steele-Mortimer O., DeVinny R., Finlay B.B. Identification of the intimin-binding domain of Tir of enteropathogenic Escherichia coli. Cell Microbiol. 1999;1:7\u201317. doi: 10.1046/j.1462-5822.1999.00001.x.", "ArticleIdList": ["10.1046/j.1462-5822.1999.00001.x", "11207537"]}, {"Citation": "Jarvis K.G., Giron J.A., Jerse A.N.N.E., Mcdaniel T.K., Donnenberg M.S., Kaper J.B. Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proc. Natl. Acad. Sci. USA. 1995;92:7996\u20138000. doi: 10.1073/pnas.92.17.7996.", "ArticleIdList": ["10.1073/pnas.92.17.7996", "PMC41273", "7644527"]}, {"Citation": "Franzin F.M., Sircili M.P. Locus of enterocyte effacement: A pathogenicity island involved in the virulence of enteropathogenic and enterohemorrhagic Escherichia coli subjected to a complex network of gene regulation. BioMed Res. Int. 2015;2015:534738. doi: 10.1155/2015/534738.", "ArticleIdList": ["10.1155/2015/534738", "PMC4332760", "25710006"]}, {"Citation": "Croxen M.A., Finlay B.B. Molecular mechanisms of Escherichia coli pathogenicity. Nat. Rev. Microbiol. 2010;8:26\u201338. doi: 10.1038/nrmicro2265.", "ArticleIdList": ["10.1038/nrmicro2265", "19966814"]}, {"Citation": "Dai W., Li Z. Conserved type III secretion system exerts important roles in Chlamydia trachomatis. Int. J. Exp. Pathol. 2014;7:5404\u20135414.", "ArticleIdList": ["PMC4203154", "25337183"]}, {"Citation": "Bartra S.S., Lorica C., Qian L., Gong X., Bahnan W. Chromosomally-encoded Yersinia pestis type III secretion effector proteins promote infection in cells and in mice. Front. Cell. Infect. Microbiol. 2019;9 doi: 10.3389/fcimb.2019.00023.", "ArticleIdList": ["10.3389/fcimb.2019.00023", "PMC6396649", "30854334"]}, {"Citation": "Marketon M.M., Depaolo R.W., Debord K.L. Plague bacteria target immune cells during infection. Science. 2005;309:1739\u20131742. doi: 10.1126/science.1114580.", "ArticleIdList": ["10.1126/science.1114580", "PMC3210820", "16051750"]}, {"Citation": "Crawford J.A., Kaper J.B. The N-terminus of enteropathogenic Escherichia coli (EPEC) Tir mediates transport across bacterial and eukaryotic cell membranes. Mol. Microbiol. 2002;46:855\u2013868. doi: 10.1046/j.1365-2958.2002.03214.x.", "ArticleIdList": ["10.1046/j.1365-2958.2002.03214.x", "12410841"]}, {"Citation": "Fasciano A.C., Shaban L., Mecsas J. Promises and challenges of the type three secretion system injectisome as an antivirulence target. EcoSal Plus. 2019 doi: 10.1128/ecosalplus.ESP-0032-2018.", "ArticleIdList": ["10.1128/ecosalplus.ESP-0032-2018", "PMC6367940", "30706846"]}, {"Citation": "Yang J., Hocking D.M., Cheng C., Dogovski C., Perugini M.A., Holien J.K., Parker M.W., Hartland E.L., Tauschek M., Robins-Browne R.M. Disarming bacterial virulence through chemical inhibition of the DNA binding domain of an AraC-like transcriptional activator protein. J. Biol. Chem. 2013;288:31115\u201331126. doi: 10.1074/jbc.M113.503912.", "ArticleIdList": ["10.1074/jbc.M113.503912", "PMC3829424", "24019519"]}, {"Citation": "Marshall N.C., Finlay B.B., Marshall N.C., Finlay B.B. Targeting the type III secretion system to treat bacterial infections. Expert Opin. Ther. Targets. 2014;18:137\u2013152. doi: 10.1517/14728222.2014.855199.", "ArticleIdList": ["10.1517/14728222.2014.855199", "24295327"]}, {"Citation": "Kimura K., Iwatsuki M., Nagai T., Matsumoto A., Takahashi Y., Shiomi K., Omura S., Abe A. A small-molecule inhibitor of the bacterial type III secretion system protects against in vivo infection with Citrobacter rodentium. J. Antibiot. 2011;64:197\u2013203. doi: 10.1038/ja.2010.155.", "ArticleIdList": ["10.1038/ja.2010.155", "21139624"]}, {"Citation": "Linington R.G., Robertson M., Gauthier A., Finlay B.B., Van Soest R., Andersen R.J. Caminoside A, an antimicrobial glycolipid isolated from the marine sponge Caminus sphaeroconia. Org. Lett. 2002;4:4089\u20134092. doi: 10.1021/ol0268337.", "ArticleIdList": ["10.1021/ol0268337", "12423093"]}, {"Citation": "Kola M., Urba K. Antibiotic selective pressure and development of bacterial resistance. Int. J. Antimicrob. Agents. 2001;17:357\u2013363. doi: 10.1016/S0924-8579(01)00317-X.", "ArticleIdList": ["10.1016/S0924-8579(01)00317-X", "11337221"]}, {"Citation": "Loquet A., Sgourakis N.G., Gupta R., Giller K., Riedel D., Goosmann C., Griesinger C., Kolbe M., Baker D., Becker S., et al. Atomic model of the type III secretion system needle. Nature. 2012;486:276\u2013279. doi: 10.1038/nature11079.", "ArticleIdList": ["10.1038/nature11079", "PMC3598588", "22699623"]}, {"Citation": "Cornelis G.R. The type III secretion injectisome. Nat. Rev. Microbiol. 2006;4:811\u2013825. doi: 10.1038/nrmicro1526.", "ArticleIdList": ["10.1038/nrmicro1526", "17041629"]}, {"Citation": "Gal\u00e1n J.E., Waksman G. Protein-injection machines in bacteria. Cell. 2018;172:1306\u20131318. doi: 10.1016/j.cell.2018.01.034.", "ArticleIdList": ["10.1016/j.cell.2018.01.034", "PMC5849082", "29522749"]}, {"Citation": "Sekiya K., Ohishi M., Ogino T., Tamano K., Sasakawa C., Abe A. Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure. Proc. Natl. Acad. Sci. USA. 2001;98:11638\u201311643. doi: 10.1073/pnas.191378598.", "ArticleIdList": ["10.1073/pnas.191378598", "PMC58782", "11562461"]}, {"Citation": "Bzdzion L., Krezel H., Wrzeszcz K., Grzegorek I., Nowinska K., Chodaczek G., Swietnicki W. Design of small molecule inhibitors of type III secretion system ATPase EscN from enteropathogenic Escherichia coli. Acta Biochim. Pol. 2017;64:49\u201363. doi: 10.18388/abp.2016_1265.", "ArticleIdList": ["10.18388/abp.2016_1265", "27864920"]}, {"Citation": "Andrade A., Pardo J.P., Espinosa N., P\u00e9rez-Hern\u00e1ndez G., Gonz\u00e1lez-Pedrajo B. Enzymatic characterization of the enteropathogenic Escherichia coli type III secretion ATPase EscN. Arch. Biochem. Biophys. 2007;468:121\u2013127. doi: 10.1016/j.abb.2007.09.020.", "ArticleIdList": ["10.1016/j.abb.2007.09.020", "17964526"]}, {"Citation": "Bergeron J.R.C., Fern\u00e1ndez L., Wasney G.A., Vuckovic M., Reffuveille F., Hancock R.E.W., Strynadka N.C.J. The structure of a type 3 secretion system (T3SS) ruler protein suggests a molecular mechanism for needle length sensing. J. Biol. Chem. 2016;291:1676\u20131691. doi: 10.1074/jbc.M115.684423.", "ArticleIdList": ["10.1074/jbc.M115.684423", "PMC4722450", "26589798"]}, {"Citation": "Munera D., Crepin V.F., Marches O., Frankel G. N-terminal type III secretion signal of enteropathogenic Escherichia coli translocator proteins. J. Bacteriol. 2010;192:3534\u20133539. doi: 10.1128/JB.00046-10.", "ArticleIdList": ["10.1128/JB.00046-10", "PMC2897685", "20400543"]}, {"Citation": "Deng W., Yu H.B., Li Y., Brett B. SepD/SepL-dependent secretion signals of the type III secretion system translocator proteins in enteropathogenic Escherichia coli. J. Bacteriol. 2015;197:1263\u20131275. doi: 10.1128/JB.02401-14.", "ArticleIdList": ["10.1128/JB.02401-14", "PMC4352668", "25645555"]}, {"Citation": "Shaw R.K., Cleary J., Murphy M.S., Frankel G., Knutton S. Interaction of enteropathogenic Escherichia coli with human intestinal mucosa: Role of effector proteins in brush border remodeling and formation of attaching and effacing lesions. Infect. Immun. 2005;73:1243\u20131251. doi: 10.1128/IAI.73.2.1243-1251.2005.", "ArticleIdList": ["10.1128/IAI.73.2.1243-1251.2005", "PMC547083", "15664974"]}, {"Citation": "Park D., Lara-Tejero M., Waxham M.N., Li W., Hu B. Visualization of the type III secretion-mediated Salmonella\u2013host cell interface using cryo-electron tomography. eLife Sci. 2018;7:1\u201315. doi: 10.7554/eLife.39514.", "ArticleIdList": ["10.7554/eLife.39514", "PMC6175578", "30281019"]}, {"Citation": "Creasey E.A., Delahay R.M., Bishop A.A., Shaw R.K., Kenny B., Knutton S., Frankel G. CesT Is a bivalent enteropathogenic Escherichia coli chaperone required for translocation of both Tir and Map. Mol. Microbiol. 2003;47:209\u2013221. doi: 10.1046/j.1365-2958.2003.03290.x.", "ArticleIdList": ["10.1046/j.1365-2958.2003.03290.x", "12492865"]}, {"Citation": "Haack K.R., Robinson C.L., Miller K.J., Fowlkes J.W., Mellies J.L. Interaction of Ler at the LEE5 (Tir) operon of enteropathogenic Escherichia coli. Infect. Immun. 2003;71:384\u2013392. doi: 10.1128/IAI.71.1.384-392.2003.", "ArticleIdList": ["10.1128/IAI.71.1.384-392.2003", "PMC143144", "12496188"]}, {"Citation": "Abe A., De Grado M., Pfuetzner R.A., S\u00e1nchez-Sanmart\u00edn C., Puente \u00c2.L., Devinney R., Strynadka N.C., Finlay B.B. Enteropathogenic Escherichia coli translocated intimin receptor, Tir, requires a specific chaperone for stable secretion. Mol. Microbiol. 1999;33:1162\u20131175. doi: 10.1046/j.1365-2958.1999.01558.x.", "ArticleIdList": ["10.1046/j.1365-2958.1999.01558.x", "10510231"]}, {"Citation": "Coburn B., Sekirov I., Finlay B.B. Type III secretion systems and disease. Clin. Microbiol. Rev. 2007;20:535\u2013549. doi: 10.1128/CMR.00013-07.", "ArticleIdList": ["10.1128/CMR.00013-07", "PMC2176049", "17934073"]}, {"Citation": "Hauser A.R. The type III secretion system of Pseudomonas aeruginosa: Infection by injection. Nat. Rev. Microbiol. 2009;7:654\u2013666. doi: 10.1038/nrmicro2199.", "ArticleIdList": ["10.1038/nrmicro2199", "PMC2766515", "19680249"]}, {"Citation": "Galan J.E. Common themes in the design and function of bacterial effectors. Cell Host Microbe. 2009;5:571\u2013579. doi: 10.1016/j.chom.2009.04.008.", "ArticleIdList": ["10.1016/j.chom.2009.04.008", "PMC2729653", "19527884"]}, {"Citation": "Golubeva Y.A., Sadik A.Y., Ellermeier J.R., Slauch J.M. Integrating global regulatory input into the Salmonella pathogenicity island 1 type III secretion system. Genetics. 2012;190:79\u201390. doi: 10.1534/genetics.111.132779.", "ArticleIdList": ["10.1534/genetics.111.132779", "PMC3249375", "22021388"]}, {"Citation": "Figueira R., Holden D.W. Functions of the Salmonella pathogenicity island 2 (SPI-2) type III secretion system effectors. Microbiology. 2012;2:1147\u20131161. doi: 10.1099/mic.0.058115-0.", "ArticleIdList": ["10.1099/mic.0.058115-0", "22422755"]}, {"Citation": "Winstanley C., Hart C.A. Type III secretion systems and pathogenicity islands. J. Med. Microbiol. 2001;50:116\u2013126. doi: 10.1099/0022-1317-50-2-116.", "ArticleIdList": ["10.1099/0022-1317-50-2-116", "11211218"]}, {"Citation": "Wang H., Avican K., Fahlgren A., Erttmann S.F., Nuss A.M., Dersch P., Fallman M., Edgren T., Wolf-Watz H. Increased plasmid copy number is essential for Yersinia T3SS function and virulence. Science. 2016;353:492\u2013495. doi: 10.1126/science.aaf7501.", "ArticleIdList": ["10.1126/science.aaf7501", "27365311"]}, {"Citation": "Mcdaniel T.K., Jarvis K.G., Donnenberg M.S., Kaper J.B. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc. Natl. Acad. Sci. USA. 1995;92:1664\u20131668. doi: 10.1073/pnas.92.5.1664.", "ArticleIdList": ["10.1073/pnas.92.5.1664", "PMC42580", "7878036"]}, {"Citation": "Elliott S.J., Sperandio V., Giron J.A., Wainwright L., Hutcheson S.W., McDaniel T.K. The locus of enterocyte effacement (LEE)-encoded regulator controls expression of both LEE- and non-LEE-encoded virulence factors in enteropathogenic and enterohemorrhagic Escherichia coli. Infect. Immun. 2000;68:6115\u20136126. doi: 10.1128/IAI.68.11.6115-6126.2000.", "ArticleIdList": ["10.1128/IAI.68.11.6115-6126.2000", "PMC97688", "11035714"]}, {"Citation": "Deng W., Li Y., Vallance B.A., Finlay B.B. Locus of enterocyte effacement from Citrobacter rodentium: Sequence analysis and evidence for horizontal transfer among attaching and effacing pathogens. Am. Soc. Microbiol. 2001;69:6323\u20136335. doi: 10.1128/IAI.69.10.6323-6335.2001.", "ArticleIdList": ["10.1128/IAI.69.10.6323-6335.2001", "PMC98768", "11553577"]}, {"Citation": "Vidal J.E., Navarro-Garc\u00eda F. EspC translocation into epithelial cells by enteropathogenic Escherichia coli requires a concerted participation of type V and III secretion systems. Cell. Microbiol. 2008;10:1975\u20131986. doi: 10.1111/j.1462-5822.2008.01181.x.", "ArticleIdList": ["10.1111/j.1462-5822.2008.01181.x", "18547338"]}, {"Citation": "Sun J., Xiuwen H., Yu B. First total synthesis of caminoside A, an antimicrobial glycolipid from sponge. Synlett. 2005;3:437\u2013440. doi: 10.1002/chin.200530186.", "ArticleIdList": ["10.1002/chin.200530186"]}, {"Citation": "Zhang Z., Zong C., Song G., Lv G., Chun Y., Wang P., Ding N., Li Y. Total synthesis of caminoside B, a novel antimicrobial glycolipid isolated from the marine sponge Caminus sphaeroconia. Carbohydr. Res. 2010;345:750\u2013760. doi: 10.1016/j.carres.2010.01.015.", "ArticleIdList": ["10.1016/j.carres.2010.01.015", "20170905"]}, {"Citation": "Berger J., Lehr H.H., Teitel S., Maehr H., Grunberg E. A new antibiotic X-5108 of Streptomyces origin. I. Production, isolation and properties. J. Antibiot. 1973;26:15\u201322. doi: 10.7164/antibiotics.26.15.", "ArticleIdList": ["10.7164/antibiotics.26.15", "4781274"]}, {"Citation": "Chinali G. Synthetic Analogs of aurodox and kirromycin active on elongation factor Tu from Escherichia coli. J. Antibiot. 1981;34:1039\u20131045. doi: 10.7164/antibiotics.34.1039.", "ArticleIdList": ["10.7164/antibiotics.34.1039", "6119303"]}, {"Citation": "Warawa J., Finlay B.B., Kenny B. Type III secretion-dependent hemolytic activity of enteropathogenic Escherichia coli. Infect. Immun. 1999;67:5538\u20135540.", "ArticleIdList": ["PMC96921", "10496946"]}, {"Citation": "Swimm A.I., Kalman D. Cytosolic extract induces Tir translocation and pedestals in EPEC-infected red blood cells. PLoS Pathog. 2008;4:e4. doi: 10.1371/journal.ppat.0040004.", "ArticleIdList": ["10.1371/journal.ppat.0040004", "PMC2211550", "18208322"]}, {"Citation": "Simpson N., Shaw R., Crepin V.F., Mundy R., Fitzgerald A.J., Straatman-Iwanowska A., Knutton S., Frankel G. The enteropathogenic Escherichia coli type III secretion system effector Map binds EBP50/NHERF1: Implication for cell signaling and diarrhea. Mol. Microbiol. 2006;60:349\u2013363. doi: 10.1111/j.1365-2958.2006.05109.x.", "ArticleIdList": ["10.1111/j.1365-2958.2006.05109.x", "16573685"]}, {"Citation": "McHugh R.E., O\u2019Boyle N., Connoly J.P.R., Hoskisson P.A., Roe A.J. Characterization of the mode of action of aurodox, a type III secretion system inhibitor from Streptomyces goldiniensis. Infect. Immun. 2019;87:1\u201312. doi: 10.1128/IAI.00595-18.", "ArticleIdList": ["10.1128/IAI.00595-18", "PMC6346137", "30455200"]}, {"Citation": "Tamura S., Takahashi N., Miyamoto S., Mori R., Suzuki S., Nagatsu J. Isolation and physiological activities of piericidin A, a natural insecticide produced by Streptomyces. Agric. Biol. Chem. 1963;27:576\u2013582. doi: 10.1080/00021369.1963.10858144.", "ArticleIdList": ["10.1080/00021369.1963.10858144"]}, {"Citation": "Hall C., Wu M., Crane F.L. Piericidin A: A new inhibitor of mitochondrial electron transport. Biochem. Biophys. Res. Commun. 1966;25:373\u2013377. doi: 10.1016/0006-291X(66)90214-2.", "ArticleIdList": ["10.1016/0006-291X(66)90214-2", "4290528"]}, {"Citation": "Kroiss J., Kaltenpoth M., Schneider B., Schwinger M., Hertweck C., Maddula R.K., Strohm E., Svato\u0161 A. Symbiotic Streptomycetes provide antibiotic combination prophylaxis for wasp offspring. Nat. Chem. Biol. 2010;6:261\u2013263. doi: 10.1038/nchembio.331.", "ArticleIdList": ["10.1038/nchembio.331", "20190763"]}, {"Citation": "Duncan M.C., Wong R., Dupzyk A.J., Bray W.M., Linington R.G. Inhibitors of the Yersinia pseudotuberculosis type III secretion system. Antimicrob. Agents Chemother. 2014;58:1118\u20131126. doi: 10.1128/AAC.02025-13.", "ArticleIdList": ["10.1128/AAC.02025-13", "PMC3910828", "24295981"]}, {"Citation": "Auerbuch V., Golenbock D.T., Isberg R.R. Innate immune recognition of Yersinia pseudotuberculosis type III secretion. PLoS Pathog. 2009;5:e1000686. doi: 10.1371/journal.ppat.1000686.", "ArticleIdList": ["10.1371/journal.ppat.1000686", "PMC2779593", "19997504"]}, {"Citation": "Morgan J.M., Duncan M.C., Johnson K.S., Diepold A., Lam H., Dupzyk A.J., Martin L.R., Wong R., Armitage J.P., Linington R.G. Piericidin A1 blocks Yersinia Ysc type III secretion system needle assembly. Am. Soc. Microbiol. 2017;2:1\u201314. doi: 10.1128/mSphere.00030-17.", "ArticleIdList": ["10.1128/mSphere.00030-17", "PMC5311113", "28217742"]}, {"Citation": "Zhan Y., Du X., Chen H., Liu J., Zhao B., Huang D., Li G., Xu Q., Zhang M., Weimer B.C., et al. Cytosporone B is an agonist for nuclear orphan receptor Nur77. Nat. Chem. Biol. 2008;4:548\u2013556. doi: 10.1038/nchembio.106.", "ArticleIdList": ["10.1038/nchembio.106", "18690216"]}, {"Citation": "Xia Z., Cao X., Rico-bautista E., Yu J., Chen L., Chen J., Bobkov A., Wolf D.A., Zhang X., Dawson M.I. Cytosporone B on cancer cell viability. Med. Chem. Commun. 2013;4:332\u2013339. doi: 10.1039/C2MD20243C.", "ArticleIdList": ["10.1039/C2MD20243C", "PMC4005383", "24795803"]}, {"Citation": "Chen H., Liu Q., Li L., Wang W., Yao L., Yang M., Liu B., Chen W., Zhan Y., Zhang M., et al. The orphan receptor TR3 suppresses intestinal tumorigenesis in mice by downregulating wnt signaling. Gastrointrotestinal Neoplasia. 2012;61:714\u2013724.", "ArticleIdList": ["21873734"]}, {"Citation": "Lee S., Li X., Khan S., Safe S. Targeting NR4A1 (TR3) in cancer cells and tumors. Expert Opin. Ther. Targets. 2011;15:195\u2013206. doi: 10.1517/14728222.2011.547481.", "ArticleIdList": ["10.1517/14728222.2011.547481", "PMC4407471", "21204731"]}, {"Citation": "Li J., Lv C., Sun W., Li Z., Han X., Li Y., Shen Y. Cytosporone B, an inhibitor of the type III secretion system of Salmonella enterica serovar Typhimurium. Antimicrob. Agents Chemother. 2013;57:2191\u20132198. doi: 10.1128/AAC.02421-12.", "ArticleIdList": ["10.1128/AAC.02421-12", "PMC3632957", "23459474"]}, {"Citation": "Huang H., Zhang L., Zhang X., Ji X., Ding X., Shen X., Jiang H., Liu H. Total synthesis of cytosporone B. Chin. J. Chem. 2010;28:1041\u20131043. doi: 10.1002/cjoc.201090163.", "ArticleIdList": ["10.1002/cjoc.201090163"]}, {"Citation": "Iwatsuki M., Uchida R., Yoshijima H., Ui H., Shiomi K., Matsumoto A., Takahashi Y., Abe A., Tomoda H., Satoshi O. Guadinomines, type III secretion system inhibitors, produced by Streptomyces sp. K01-0509 I. Taxonomy, fermentation, isolation and biological properties. J. Antibiot. 2008;61:222\u2013229. doi: 10.1038/ja.2008.32.", "ArticleIdList": ["10.1038/ja.2008.32", "18503201"]}, {"Citation": "Iwatsuki M., Uchida R., Yoshijima H., Ui H., Shiomi K., Kim Y., Hirose T., Sunazuka T., Abe A., Tomoda H. Guadinomines, type III secretion system inhibitors, produced by Streptomyces sp. K01-0509. II. Physico-chemical properties and structure elucidation. J. Antibiot. 2008;61:230\u2013236. doi: 10.1038/ja.2008.33.", "ArticleIdList": ["10.1038/ja.2008.33", "18503202"]}, {"Citation": "Hirose T., Sunazuka T., Tsuchiya S., Tanaka T., Kojima Y., Mori R., Iwatsuki M., \u014cmura S. Total synthesis and determination of the absolute configuration of guadinomines B and C2. Chem. Eur. J. 2008;14:8220\u20138238. doi: 10.1002/chem.200801024.", "ArticleIdList": ["10.1002/chem.200801024", "18655091"]}, {"Citation": "Holmes T.C., May A.E., Zaleta-Rivera K., Ruby J.G., Skewes-Cox P., Fischbach M.A., Derisi J.L., Iwatsuki M., Satoshi O., Khosla C. Molecular insights into the biosynthesis of guadinomine: A type III secretion system inhibitor. J. Am. Chem. Soc. 2012;134:17797\u201317806. doi: 10.1021/ja308622d.", "ArticleIdList": ["10.1021/ja308622d", "PMC3483642", "23030602"]}, {"Citation": "Bohnhoff B.Y.M., Miller C.P., Martin W.R. Resistance of the mouse\u2019s intestinal tract to experimental Salmonella infection I. Factors which interfere with the initiation of infection. J. Exp. Med. 1964;120:805\u2013816. doi: 10.1084/jem.120.5.805.", "ArticleIdList": ["10.1084/jem.120.5.805", "PMC2137858", "14247721"]}, {"Citation": "Sun Y., O\u2019Riordan M.X. Regulation of bacterial pathogenesis by intestinal short-chain fatty acids. Adv. Appl. Microbiol. 2013;85:93\u2013118.", "ArticleIdList": ["PMC4029053", "23942149"]}, {"Citation": "Nakanishi N., Tashiro K., Kuhara S., Hayashi T., Sugimoto N., Tobe T. Regulation of virulence by butyrate sensing in enterohaemorrhagic Escherichia coli. Microbiology. 2009;155:521\u2013530. doi: 10.1099/mic.0.023499-0.", "ArticleIdList": ["10.1099/mic.0.023499-0", "19202100"]}, {"Citation": "Pomare E.W., Branch H.W.J., Naylor C.P.E., Macfarlane T. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28:1221\u20131227.", "ArticleIdList": ["PMC1433442", "3678950"]}, {"Citation": "Takao M., Yen H., Tobe T. LeuO Enhances butyrate-induced virulence expression through a positive regulatory loop in enterohaemorrhagic Escherichia coli. Mol. Microbiol. 2014;93:1302\u20131313.", "ArticleIdList": ["25069663"]}, {"Citation": "Baek C., Wang S., Roland K.L., Curtiss R., III Leucine-responsive regulatory protein (Lrp) acts as a virulence repressor in Salmonella enterica serovar Typhimurium. J. Bacteriol. 2009;191:1278\u20131292. doi: 10.1128/JB.01142-08.", "ArticleIdList": ["10.1128/JB.01142-08", "PMC2631999", "19074398"]}, {"Citation": "Cordone A., Lucchini S., De Felice M., Ricca E. Direct and indirect control of Lrp on LEE pathogenicity genes of Citrobacter rodentium. Fed. Eur. Microbiol. Soc. 2011;325:64\u201370. doi: 10.1111/j.1574-6968.2011.02411.x.", "ArticleIdList": ["10.1111/j.1574-6968.2011.02411.x", "22092863"]}, {"Citation": "Crutcher F.K., Puckhaber L.S., Stipanovic R.D., Bell A.A., Nichols R.L., Lawrence K.S., Liu J. Microbial resistance mechanisms to the antibiotic and phytotoxin fusaric acid. J. Chem. Ecol. 2017;43:996\u20131006. doi: 10.1007/s10886-017-0889-x.", "ArticleIdList": ["10.1007/s10886-017-0889-x", "28986689"]}, {"Citation": "Gaumman E. Fusaric acid as a wilt toxin. Phytopathology. 1957;47:342\u2013357."}, {"Citation": "Dong X., Ling N., Wang M., Shen Q., Guo S. Fusaric acid is a crucial factor in the disturbance of leaf water imbalance in Fusarium-infected banana plants. Plant. Physiol. Biochem. 2012;60:171\u2013179. doi: 10.1016/j.plaphy.2012.08.004.", "ArticleIdList": ["10.1016/j.plaphy.2012.08.004", "22964424"]}, {"Citation": "Reveglia P., Cinelli T., Cimmino A., Masi M., Evidente A. The main phytotoxic metabolite produced by a strain of Fusarium oxysporum inducing grapevine plant declining in Italy. Nat. Prod. Res. 2017;32:2398\u20132407. doi: 10.1080/14786419.2017.1415897.", "ArticleIdList": ["10.1080/14786419.2017.1415897", "29237292"]}, {"Citation": "Li J., Sun W., Guo Z., Lu C., Shen Y. Fusaric acid modulates type three secretion system of Salmonella enterica serovar Typhimurium. Biochem. Biophys. Res. Commun. 2014;449:455\u2013459. doi: 10.1016/j.bbrc.2014.05.044.", "ArticleIdList": ["10.1016/j.bbrc.2014.05.044", "24853802"]}, {"Citation": "Zetterstr\u00f6m C.E., Hasselgren J., Salin O., Davis R.A., Quinn R.J. The resveratrol tetramer (-)-hopeaphenol inhibits type III secretion in the Gram-negative pathogens Yersinia pseudotuberculosis and Pseudomonas aeruginosa. PLoS ONE. 2013;8:e81969. doi: 10.1371/journal.pone.0081969.", "ArticleIdList": ["10.1371/journal.pone.0081969", "PMC3853165", "24324737"]}, {"Citation": "Subramanian R., Raj V., Manigandan K., Elangovan N. Antioxidant activity of hopeaphenol isolated from Shorea roxburghii stem bark extract. J. Taibah Univ. Sci. 2015;9:237\u2013244. doi: 10.1016/j.jtusci.2014.11.004.", "ArticleIdList": ["10.1016/j.jtusci.2014.11.004"]}, {"Citation": "International Union for Conservation of Nature (IUCN) Red List.  [(accessed on 5 September 2019)]; Available online:  https://www.iucnredlist.org/search?query=anisoptera&searchType=species."}, {"Citation": "Babich H., Zuckerbraun H.L., Barber I.B., Babich S.B., Borenfreund E. Cytotoxicity of sanguinarine chloride to cultured human cells from oral tissue. Pharmacol. Toxicol. 1996;78:397\u2013403. doi: 10.1111/j.1600-0773.1996.tb00225.x.", "ArticleIdList": ["10.1111/j.1600-0773.1996.tb00225.x", "8829200"]}, {"Citation": "Mondal A., Gandhi A., Fimognari C., Atanasov A.G., Bishayee A. Alkaloids for cancer prevention and therapy: Current progress and future perspectives. Eur. J. Pharmacol. 2019;858 doi: 10.1016/j.ejphar.2019.172472.", "ArticleIdList": ["10.1016/j.ejphar.2019.172472", "31228447"]}, {"Citation": "Zhang Y., Liu Y., Wang T., Deng X., Chu X. Natural compound sanguinarine chloride targets the type III secretion system of Salmonella enterica serovar Typhimurium. Biochem. Biophys. Rep. 2018;14:149\u2013154. doi: 10.1016/j.bbrep.2018.04.011.", "ArticleIdList": ["10.1016/j.bbrep.2018.04.011", "PMC5948472", "29761161"]}, {"Citation": "Zhang Y., Liu Y., Qiu J., Luo Z., Deng X. The herbal compound thymol protects mice from lethal infection by Salmonella typhimurium. Front. Microbiol. 2018;9:1\u20137. doi: 10.3389/fmicb.2018.01022.", "ArticleIdList": ["10.3389/fmicb.2018.01022", "PMC5968388", "29867906"]}, {"Citation": "Ghannadi A., Ebrahim S., Kabouche A. Thymus Fontanesii Boiss. & Reut: A potential source of thymol-rich essential oil in North Africa. Zeitschrift fur Naturforschung C. 2004;59:187\u2013189.", "ArticleIdList": ["15241923"]}, {"Citation": "Yang S., Peng Q., Francisco M.S., Wang Y., Zeng Q., Yang C. Type III secretion system genes of Dickeya dadantii 3937 are induced by plant phenolic acids. PLoS ONE. 2008;3:e2973. doi: 10.1371/annotation/91170966-226f-4678-999e-22f2c4a6bb8d.", "ArticleIdList": ["10.1371/annotation/91170966-226f-4678-999e-22f2c4a6bb8d", "PMC2494611", "18698421"]}, {"Citation": "Khokhani D., Zhang C., Li Y., Wang Q., Zeng Q., Yamazaki A., Hutchins W., Zhou S., Chen X., Yang C. Discovery of plant phenolic compounds that act as type III secretion system inhibitors or inducers of the fire blight pathogen, Erwinia amylovora. Appl. Environ. Microbiol. 2013;79:5424\u20135436. doi: 10.1128/AEM.00845-13.", "ArticleIdList": ["10.1128/AEM.00845-13", "PMC3754148", "23770912"]}]}], "History": [{"Year": "2019", "Month": "9", "Day": "10"}, {"Year": "2019", "Month": "9", "Day": "18"}, {"Year": "2019", "Month": "9", "Day": "19"}, {"Year": "2019", "Month": "9", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "9", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "9", "Day": "27", "Hour": "6", "Minute": "1"}, {"Year": "2019", "Month": "9", "Day": "24"}], "PublicationStatus": "epublish", "ArticleIdList": ["31554164", "PMC6963908", "10.3390/antibiotics8040162", "antibiotics8040162"]}}]}